Lung cancer medicines
Lung cancer medicines depend on histology and biomarkers (PD-L1, EGFR, and others). This page groups immunotherapy and targeted tablets we stock. It does not replace molecular testing.
Immunotherapy such as pembrolizumab (Keytruda) or nivolumab (Opdivo) is used in selected NSCLC and other settings.
EGFR-mutated NSCLC may use osimertinib (Tagrisso) tablets instead of, or sequenced with, other systemic therapy.
Bevacizumab (Avastin) is sometimes combined with chemotherapy in eligible non-squamous NSCLC.
Medicines we stock in this area
Each card opens the existing /shop product URL. Protocols are chosen only by the oncologist.
PD-1
Keytruda Pembrolizumab 100mg
Open productPD-1
Opdivo Nivolumab 240mg
Open productEGFR
Tagrisso Osimertinib 80mg
Open productVEGF
Avastin Bevacizumab 400mg
Open productInformation and pharmacy-access support only — not medical advice, diagnosis, or a treatment plan. Always follow your oncologist. Prescription required for oncology medicines.